SCHEMBL4481629

SCHEMBL4481629

O=C(O)c1cc2ccc(O)cc2nc1Nc1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 3/20 0.46
CSNK2A2 P19784 2/20 0.46
CSNK2B P67870 2/20 0.46
FTO Q9C0B1 4/20 0.44
TRPV1 Q8NER1 1/20 0.44
PIM1 P11309 2/20 0.44
PIM2 Q9P1W9 1/20 0.44
AURKA O14965 2/20 0.43
GRIK1 P39086 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
TTR P02766 1/20 0.42
MAPT P10636 1/20 0.41
FABP3 P05413 1/20 0.41
FABP4 P15090 1/20 0.41
FABP5 Q01469 1/20 0.41
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
JAK3 P52333 1/20 0.41
PDE5A O76074 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4476369 0.87 HTT (0.46) CSNK2A1CSNK2A2CSNK2BTRPV1AURKA
SCHEMBL4490345 0.83 FABP3 (0.51) CSNK2A1CSNK2A2CSNK2BAURKASMN1; SMN2
SCHEMBL4481316 0.80 CSNK2A1 (0.41) CSNK2A1CSNK2A2CSNK2BFTOPIM1
SCHEMBL4503390 0.79 PIM1 (0.55) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL30038771 0.74 CSNK2B (0.50) CSNK2A1CSNK2A2CSNK2BPIM1PIM2
SCHEMBL13973636 0.73 MAPK10 (0.51) PIM1PIM2SMN1; SMN2MAPTFABP3
SCHEMBL4486500 0.72 TACR3 (0.51) SMN1; SMN2MAPTJAK2TYK2
SCHEMBL13973637 0.72 NPC1 (0.58) SMN1; SMN2MAPT
SCHEMBL13961569 0.72 NPC1 (0.46) SMN1; SMN2MAPTFABP3FABP4
SCHEMBL24596386 0.72 TAS2R14 (0.52) CSNK2A1CSNK2BPIM1PIM2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7482455-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-01-27 US claimed
EP-1556379-A4 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-06-13 EP claimed
US-20060106058-A1 Chemical compounds BURGESS JOELLE L 2006-05-18 US claimed
EP-1556379-A2 CHEMICAL COMPOUNDS SmithKline Beecham Corporation (US) 2005-07-27 EP claimed
WO-2004034985-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-04-29 WO claimed
US-7482455-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-01-27 US disclosed
US-7482455-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-01-27 US disclosed
US-7482455-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2009-01-27 US disclosed
EP-1556379-A4 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2007-06-13 EP disclosed
US-20060106058-A1 Chemical compounds BURGESS JOELLE L 2006-05-18 US disclosed
EP-1556379-A2 CHEMICAL COMPOUNDS SmithKline Beecham Corporation (US) 2005-07-27 EP disclosed
WO-2004034985-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106058-A1 Chemical compounds YARS1, DAPK3, NEK3 CSNK2A1 248/4885CSNK2A2 239/4885CSNK2B 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.